GlaxoSmithKline PharmaceuticalsGLAXO 
$35.131.00%24h
1.00%24h
Global rank2461
Market cap$5.95B
Change 7d-0.87%
YTD Performance54.47%
SP500 benchmarkOutperform
P/E0.97
P/S15.34
Revenue$387.97M
Earnings$72.86M
Dividend yield-
Main Sector
Healthcare
Category
GlaxoSmithKline Pharmaceuticals (GLAXO) Net Assets
GLAXO Net Assets in 2023: $17.41B
As of 26 Aug 2024, GlaxoSmithKline Pharmaceuticals net assets is $17.41B, an decrease of -34.61% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the GlaxoSmithKline Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
GlaxoSmithKline Pharmaceuticals Net Assets History from 2019 to 2024
-
Value:-
GLAXO Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $17.41B | -34.61% |
| 2022 | $26.63B | 80.14% |
| 2021 | $14.78B | -18.80% |
| 2020 | $18.21B | 34.16% |
| 2019 | $13.57B | - |
View the Top Net Assets Companies
